SINCLAIR MICHAEL sold 19.4% of their position (7.90K shares) of OPIANT PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $96.7K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/13/2022ACC: 0001385508-22-000074
Director10% Owner
Since Sep 2019
-7.90K
Net shares
Net seller
$96.7K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
7.90K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−7.90K
Price / share
$12.25
Trade value
$96.73K
% of position
19.4%
6/9/2022
40.73K→32.84K
Total
Net shares
−7.90K
Net value
-$96.73K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/9/2022 | S · Sale | −7.90K | $12.25 | $96.73K | 19.4% | 40.73K | 32.84K |
| Total | −7.90K | -$96.73K | ||||||
Derivative Transactions0
No derivative transactions reported